Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00335803 · ClinicalTrials.gov registry record
A Research Study To Compare Two Kinds Of Daily Headache
A clinical trial of Migraine, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 1
- Study location
NCT00335803 is a study of Migraine that has completed, run by Thomas Jefferson University. The trial reports 1 study location across 1 state.
The verdict
NCT00335803, a study of Migraine, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 1
- Study location
Study Summary
Chronic daily headache has been classified into several categories. One category is of sudden onset and is called New Daily Persistent Headache (NDPH). Another category of daily headache evolves gradually and is called Transformed Migraine (TM). This research study is being conducted to compare people with these two kinds of daily headache in order to improve our understanding of these conditions.
Conditions Studied
Study Locations (1)
Pennsylvania
- Jefferson Headache Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-03 |
| Est. Completion | 2007-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00335803
The ClinicalTrials.gov registry entry for NCT00335803 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 0 interventions.
NCT00335803 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00335803 about?
NCT00335803 is a clinical study titled "A Research Study To Compare Two Kinds Of Daily Headache". Chronic daily headache has been classified into several categories. One category is of sudden onset and is called New Daily Persistent Headache (NDPH). Another category of daily headache evolves gradually and is called Transformed Migraine (TM). This research study is being conducted to compare peop...
What is the current status of trial NCT00335803?
This trial is currently completed. The study started on 2006-03. Estimated completion is 2007-09.
What conditions does trial NCT00335803 study?
This clinical trial studies the following conditions: Migraine.
Who is sponsoring clinical trial NCT00335803?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00335803 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Migraine Manager (R01)
RECRUITING · Phase 2
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
RECRUITING
-
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
RECRUITING · Phase 3
-
Mechanistic Studies of Psilocybin in Headache Disorders
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.